The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Distinct Patterns of Dendritic Cell Cytokine Release Stimulated by Fungal β-Glucans and Toll-Like Receptor Agonists
Open accessAbstract
beta-Glucans derived from fungal cell walls have potential uses as immunomodulating agents and vaccine adjuvants. Yeast glucan particles (YGPs) are highly purified Saccharomyces cerevisiae cell walls composed of beta1,6-branched beta1,3-d-glucan and free of mannans. YGPs stimulated secretion of the proinflammatory cytokine tumor necrosis factor alpha (TNF-alpha) in wild-type murine bone marrow-derived myeloid dendritic cells (BMDCs) but did not stimulate interleukin-12p70 (IL-12p70) production. A purified soluble beta1,6-branched beta1,3-d-glucan, scleroglucan, also stimulated TNF-alpha in BMDCs. These two beta-glucans failed to stimulate TNF-alpha in Dectin-1 (beta-glucan receptor) knockout BMDCs. Costimulation of wild-type BMDCs with beta-glucans and specific Toll-like receptor (TLR) ligands resulted in greatly enhanced TNF-alpha production but decreased IL-12p70 production compared with TLR agonists alone. The upregulation of TNF-alpha and downregulation of IL-12p70 required Dectin-1, but not IL-10. Gamma interferon (IFN-gamma) priming did not overcome IL-12p70 reduction by beta-glucans. Similar patterns of cytokine regulation were observed in human monocyte-derived dendritic cells (DCs) costimulated with YGPs and the TLR4 ligand lipopolysaccharide. Finally, costimulation of BMDCs with YGPs and either the TLR9 ligand, CpG, or the TLR2/1 ligand, Pam(3)CSK(4), resulted in upregulated secretion of IL-1alpha and IL-10 and downregulated secretion of IL-1beta, IL-6, and IFN-gamma-inducible protein 10 but had no significant effects on IL-12p40, keratinocyte-derived chemokine, monocyte chemotactic protein 1, or macrophage inflammatory protein alpha, compared with the TLR ligand alone. Thus, beta-glucans have distinct effects on cytokine responses following DC stimulation with different TLR agonists. These patterns of response might contribute to the skewing of immune responses during mycotic infections and have implications for the design of immunomodulators and vaccines containing beta-glucans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Stimulation of TLRs by agonists seems to be a promising strategy to enhance vaccine efficacy, because TLR triggering can induce the production of cytokines by APCs, and can promote germinal center antibody production (217, 218).”
From Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention (2019) · cites this paper as [217]
In the citing paper
“Stimulation of TLRs by agonists seems to be a promising strategy to enhance vaccine efficacy, because TLR triggering can induce the production of cytokines by APCs, and can promote germinal center antibody production (217, 218).”
From Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention (2019) · cites this paper as [217]
In the citing paper
“Stimulation of TLRs by agonists seems to be a promising strategy to enhance vaccine efficacy, because TLR triggering can induce the production of cytokines by APCs, and can promote germinal center antibody production (217, 218).”
From Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention (2019) · cites this paper as [217]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
Sallusto, F., & Lanzavecchia, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1109 · Cited by 5,129
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
Interleukin-12 and the regulation of innate resistance and adaptive immunity
Trinchieri, G. (2003) · Nature reviews. Immunology · doi:10.1038/nri1001 · Cited by 4,007
Lutz, M. B., Kukutsch, N. A., Ogilvie, A. L. J., Rößner, S., Koch, F., Romani, N., & Schuler, G. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00204-x · Cited by 2,972
Collaborative Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2
Gantner, B. N., Simmons, R. M., Canavera, S. J., Akira, S., & Underhill, D. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021787 · Cited by 1,682
Brown, G. D., & Gordon, S. (2001) · Nature · doi:10.1038/35092620 · Cited by 1,579
The structure and synthesis of the fungal cell wall
Bowman, S. M., & Free, S. J. (2006) · BioEssays · doi:10.1002/bies.20441 · Cited by 1,320
Dectin-1 is required for β-glucan recognition and control of fungal infection
Taylor, P. R., Tsoni, S. V., Willment, J. A., Dennehy, K. M., Rosas, M., Findon, H., Haynes, K., Steele, C. H., Botto, M., Gordon, S., et al. (2006) · Nature Immunology · doi:10.1038/ni1408 · Cited by 1,185
Hirschfeld, M. J., Ma, Y., Weis, J. H., Vogel, S. N., & Weis, J. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.618 · Cited by 1,155
Cited by
Sorted by citations
Romani, L. (2011) · Nature Reviews Immunology · doi:10.1038/nri2939 · Cited by 1,793
Aiello, A., Farzaneh, F., Candore, G., Caruso, C., Davinelli, S., Gambino, C. M., Ligotti, M. E., Zareian, N., & Accardi, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02247 · Cited by 693
Toll-like receptors in immunity and inflammatory diseases: Past, present, and future
Kumar, V. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.03.002 · Cited by 665
C-type lectin receptors orchestrate antifungal immunity
Hardison, S. E., & Brown, G. D. (2012) · Nature Immunology · doi:10.1038/ni.2369 · Cited by 460
Vascular endothelial cell Toll-like receptor pathways in sepsis
Khakpour, S., Wilhelmsen, K., & Hellman, J. (2015) · Innate Immunity · doi:10.1177/1753425915606525 · Cited by 239
Exit from dormancy in microbial organisms
Dworkin, J. E., & Shah, I. M. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2453 · Cited by 198
Innate Recognition of Fungal Cell Walls
Levitz, S. M. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000758 · Cited by 187
Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines
Demento, S. L., Siefert, A. L., Bandyopadhyay, A., Sharp, F. A., & Fahmy, T. M. (2011) · Trends in biotechnology · doi:10.1016/j.tibtech.2011.02.004 · Cited by 177
Huang, H., Ostroff, G. R., Lee, C. K., Specht, C. A., & Levitz, S. M. (2010) · mBio · doi:10.1128/mbio.00164-10 · Cited by 168
Carbohydrate-based immune adjuvants
Petrovsky, N., & Cooper, P. D. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.30 · Cited by 157
Delivery strategies to enhance oral vaccination against enteric infections
Davitt, C. J. H., & Lavelle, E. C. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.03.007 · Cited by 160
β-Glucan microparticles are good candidates for mucosal antigen delivery in oral vaccination
Smet, R. D., Demoor, T., Verschuere, S., Dullaers, M., Ostroff, G. R., Leclercq, G., Allais, L., Pilette, C., Dierendonck, M., Geest, B. G. D., et al. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.007 · Cited by 158
Xu, X., Yan, H., Tang, J., Chen, J., & Zhang, X. (2012) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2011.587616 · Cited by 152
The Interaction of Human Pathogenic Fungi With C-Type Lectin Receptors
Goyal, S., Castrillón-Betancur, J. C., Klaile, E., & Slevogt, H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01261 · Cited by 148
Glucan Particles for Macrophage Targeted Delivery of Nanoparticles
Soto, E. R., Caras, A. C., Kut, L. C., Castle, M. K., & Ostroff, G. R. (2011) · Journal of Drug Delivery · doi:10.1155/2012/143524 · Cited by 142
Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based Nanoparticles
Zhang, M., Kim, J. A., & Huang, A. Y.-C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00341 · Cited by 130
Ramirez-Ortiz, Z. G., Lee, C. K., Wang, J. P., Boon, L., Specht, C. A., & Levitz, S. M. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.04.007 · Cited by 121
Inulin and Its Application in Drug Delivery
Afinjuomo, F., Abdella, S., Youssef, S. H., Song, Y., & Garg, S. (2021) · Pharmaceuticals · doi:10.3390/ph14090855 · Cited by 120
Cohen, N. R., Tatituri, R. V. V., Rivera, A., Watts, G. F. M., Kim, E. Y., Chiba, A., Fuchs, B. B., Mylonakis, E., Besra, G. S., Levitz, S. M., et al. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.09.011 · Cited by 115
Relative Contributions of Dectin-1 and Complement to Immune Responses to Particulate β-Glucans
Huang, H., Ostroff, G. R., Lee, C. K., Agarwal, S., Ram, S., Rice, P. A., Specht, C. A., & Levitz, S. M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200603 · Cited by 115
Cryptococcus and Phagocytes: Complex Interactions that Influence Disease Outcome
Wager, C. M. L., Hole, C. R., Wozniak, K. L., & Wormley, F. L. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00105 · Cited by 109
Aspergillus fumigatus cell wall components differentially modulate host TLR2 and TLR4 responses
Chai, L. Y. A., Vonk, A. G., Kullberg, B. J., Verweij, P. E., Verschueren, I., van der Meer, J. W. M., Joosten, L. A. B., Latgé, J., & Netea, M. G. (2010) · Microbes and Infection · doi:10.1016/j.micinf.2010.10.005 · Cited by 101
Masuda, Y., Inoue, H., Ohta, H., Miyake, A., Konishi, M., & Nanba, H. (2012) · International Journal of Cancer · doi:10.1002/ijc.27999 · Cited by 99
Mitogen activated protein kinases SakA HOG1 and MpkC collaborate for Aspergillus fumigatus virulence
Nascimento, A. C. M. D. O. B., dos Reis, T. F., de Castro, P. A., Hori, J. I., Bom, V. L. P., de Assis, L. J., Ramalho, L. N. Z., Rocha, M. C., Malavazi, I., Brown, N. A., et al. (2016) · Molecular Microbiology · doi:10.1111/mmi.13354 · Cited by 96
Rocha, M. C., Fabri, J. H. T. M., de Godoy, K. F., de Castro, P. A., Hori, J. I., da Cunha, A. F., Arentshorst, M., Ram, A. F. J., van den Hondel, C. A. M. J. J., Goldman, G. H., et al. (2016) · G3 Genes Genomes Genetics · doi:10.1534/g3.116.031112 · Cited by 96
Recognition of yeast nucleic acids triggers a host‐protective type I interferon response
Biondo, C., Signorino, G., Costa, A., Midiri, A., Gerace, E., Galbo, R., Bellantoni, A., Malara, A., Beninati, C., Teti, G., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201141490 · Cited by 94
Specht, C. A., Lee, C. K., Huang, H., Hester, M. M., Liu, J., Luckie, B. A., Torres Santana, M. A., Mirza, Z., Khoshkenar, P., Abraham, A., et al. (2017) · mBio · doi:10.1128/mbio.01872-17 · Cited by 91
Immunosenescence and vaccine failure in the elderly: strategies for improving response
Boraschi, D., & Italiani, P. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.06.006 · Cited by 86
Specht, C. A., Lee, C. K., Huang, H., Tipper, D. J., Shen, Z. T., Lodge, J. K., Leszyk, J., Ostroff, G. R., & Levitz, S. M. (2015) · mBio · doi:10.1128/mbio.01905-15 · Cited by 88
Li, Y., Yang, Y., Chen, H., Mei, L., & Zeng, X. (2021) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2021.07.002 · Cited by 86
Potential of the β-glucans to enhance innate resistance to biological agents
Thompson, I. J., Oyston, P. C. F., & Williamson, D. E. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.10 · Cited by 81
Strain Dependent Variation of Immune Responses to A. fumigatus: Definition of Pathogenic Species
Rizzetto, L., Giovannini, G., Bromley, M., Bowyer, P., Romani, L. R., & Cavalieri, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056651 · Cited by 76
β‐glucan as a new tool in vaccine development
Větvička, V., Vannucci, L. E., & Šíma, P. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.12833 · Cited by 78
Potential of glucans as vaccine adjuvants: A review of the α-glucans case
Moreno-Mendieta, S. A., Guillén, D., Hernández‐Pando, R., Sánchez, S., & Rodrı́guez-Sanoja, R. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.02.030 · Cited by 77
Recent advances in oral vaccine development
Smet, R. D., Allais, L., & Cuvelier, C. A. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.28166 · Cited by 82
Fungal attacks on mammalian hosts: pathogen elimination requires sensing and tasting
Bourgeois, C., Majer, O., Frohner, I. E., Tierney, L., & Kuchler, K. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.05.004 · Cited by 77
Carbohydrate Conjugates in Vaccine Developments
Lang, S., & Huang, X. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00284 · Cited by 70
Exploiting fungal cell wall components in vaccines
Levitz, S. M., Huang, H., Ostroff, G. R., & Specht, C. A. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0460-6 · Cited by 71
Torrecillas, S., Montero, D., Caballero, M. J., Pittman, K., Custódio, M., Campo, A., Sweetman, J. W., & Izquierdo, M. S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00397 · Cited by 69
Identification of novel mechanisms involved in generating localized vulvodynia pain
Falsetta, M. L., Foster, D. C., Woeller, C. F., Pollock, S. J., Bonham, A. D., Haidaris, C. G., Stodgell, C. J., & Phipps, R. P. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.02.002 · Cited by 69
Developing a vaccine against aspergillosis
Stevens, D. A., Clemons, K. V., & Liu, M. (2010) · Medical Mycology · doi:10.3109/13693786.2010.497775 · Cited by 65
Jesus, M. D., Ostroff, G. R., Levitz, S. M., Bartling, T. R., & Mantis, N. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091002 · Cited by 67
Beta-Glucan Particles as Vaccine Adjuvant Carriers
Mirza, Z., Soto, E. R., Dikengil, F., Levitz, S. M., & Ostroff, G. R. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7104-6_11 · Cited by 60
Masuda, Y., Togo, T., Mizuno, S., Konishi, M., & Nanba, H. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0711386 · Cited by 60
Shin, M., Park, S. B., & Shin, K. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.02.006 · Cited by 58
Glucan and Mannan—Two Peas in a Pod
Короленко, Т. А., Bgatova, N. P., & Větvička, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133189 · Cited by 57
Soto, E. R., O'Connell, O., Dikengil, F., Peters, P., Clapham, P., & Ostroff, G. (2016) · Journal of Drug Delivery · doi:10.1155/2016/8520629 · Cited by 44
Endogenous PGE2 promotes the induction of human Th17 responses by fungal β-glucan
Gagliardi, M. C., Teloni, R., Mariotti, S., Bromuro, C., Chiani, P., Romagnoli, G., Giannoni, F., Torosantucci, A., & Nisini, R. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0310139 · Cited by 51
Combined Active Humoral and Cellular Immunization Approaches for the Treatment of Synucleinopathies
Rockenstein, E. M., Ostroff, G. R., Dikengil, F., Rus, F., Mante, M., Florio, J. B., Adame, A., Trinh, I., Kim, C., Overk, C., et al. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1170-17.2017 · Cited by 53
Soares, E. F. P., Jesus, S., & Borges, O. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.11.009 · Cited by 49
Liu, H., Jia, Z., Yang, C., Song, M. L., Jing, Z., Zhao, Y., Wu, Z., Zhao, L., Wei, D., Yin, Z., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.014 · Cited by 45
Bom, V. L. P., de Castro, P. A., Winkelströter, L. K., Mariné, M., Hori, J. I., Ramalho, L. N. Z., dos Reis, T. F., Goldman, M. H. S., Brown, N. A., Rajendran, R., et al. (2015) · Eukaryotic Cell · doi:10.1128/ec.00008-15 · Cited by 45
Current and New Approaches for Mucosal Vaccine Delivery
Rhee, J. H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811924-2.00019-5 · Cited by 46
Efficient delivery of antigen to DCs using yeast-derived microparticles
Pan, Y., Li, X., Kang, T., Meng, H., Chen, Z., Yang, L., Wu, Y., Wei, Y., & Gou, M. (2015) · Scientific Reports · doi:10.1038/srep10687 · Cited by 46
Whole glucan particles as a vaccine against murine aspergillosis
Clemons, K. V., Danielson, M. E., Michel, K. S., Liu, M., Ottoson, N. R., Leonardo, S. M., Martinez, M., Chen, V., Antonysamy, M. A., & Stevens, D. A. (2014) · Journal of Medical Microbiology · doi:10.1099/jmm.0.079681-0 · Cited by 43
Li, W., Yan, J., & Yu, Y. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1909870116 · Cited by 41
Walachowski, S., Tabouret, G., & Foucras, G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148464 · Cited by 41
Agarwal, S., Specht, C. A., Huang, H., Ostroff, G. R., Ram, S., Rice, P. A., & Levitz, S. M. (2011) · mBio · doi:10.1128/mbio.00178-11 · Cited by 40
Álvarez, Y., Rodríguez, M. R., Municio, C., Hugo, E., Alonso, S., Ibarrola, N., Fernández, N., & Crespo, M. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.391839 · Cited by 37
Deepe, G. S., Buesing, W. R., Ostroff, G. R., Abraham, A., Specht, C. A., Huang, H., & Levitz, S. M. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.04.047 · Cited by 37
Cordeiro, A. S., Crecente‐Campo, J., Bouzo, B. L., González, S., de la Fuente, M., & Alonso, M. J. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2018.1561886 · Cited by 35
Engel, A. L., Sun, G.-C., Gad, E. A., Rastetter, L., Strobe, K. L., Yang, Y., Dang, Y., Disis, M. L., & Lu, H. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.05.001 · Cited by 35
Co-recognition of β-glucan and chitin and programming of adaptive immunity to Aspergillus fumigatus
Amarsaikhan, N., & Templeton, S. P. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00344 · Cited by 36
Adjuvants and delivery systems for antifungal vaccines: Current state and future developments
Portuondo, D. L., Ferreira, L. S., Urbaczek, A. C., Batista-Duharte, A., & Carlos, I. Z. (2014) · Medical Mycology · doi:10.1093/mmy/myu045 · Cited by 33
Park, H., Lee, S. J., Im, S.-B., Shin, M., Choi, H., Park, H., & Shin, K. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.07.012 · Cited by 34
Shin, M.-S., Lee, H., Hong, H., & Shin, K. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.07.025 · Cited by 33
Chitosan:β-glucan particles as a new adjuvant for the hepatitis B antigen
Soares, E. F. P., Jesus, S., & Borges, O. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.07.018 · Cited by 33
Specifically targeted delivery of protein to phagocytic macrophages
Hong, Z., Yu, M., Chen, Z., Guo, W., Wang, J., Feng, Y., & Kong, X. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s75950 · Cited by 33
A novel antigen delivery system induces strong humoral and CTL immune responses
Yang, Z., Xu, M., Jia, Z., Zhang, Y., Wang, L., Zhang, H., Wang, J., Song, M. L., Zhao, Y., Wu, Z., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.04.035 · Cited by 31
Masuda, Y., Nawa, D., Nakayama, Y., Konishi, M., & Nanba, H. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.1a0814-415rr · Cited by 32
Berner, V. K., duPre', S. A., Redelman, D. D., & Hunter, K. W. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.10.007 · Cited by 31
Vaccine strategies to enhance immune responses in the aged
Lefebvre, J. S., & Haynes, L. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.05.014 · Cited by 32
Naglik, J. R. (2014) · New Journal of Science · doi:10.1155/2014/390241 · Cited by 29
Jeong, S., Heo, Y., Jeong, J.-H., Ham, S.-J., Yum, J. S., Ahn, B.-C., Song, C., & Chun, E. (2021) · Vaccines · doi:10.3390/vaccines9090957 · Cited by 29
Use of Biopolymers in Mucosally-Administered Vaccinations for Respiratory Disease
Dedloff, M. R., Effler, C. S., Holban, A. M., & Gestal, M. C. (2019) · Materials · doi:10.3390/ma12152445 · Cited by 28
Friend or foe: using systems biology to elucidate interactions between fungi and their hosts
Rizzetto, L., & Cavalieri, D. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.07.007 · Cited by 27
Abraham, A., Ostroff, G. R., Levitz, S. M., & Oyston, P. C. F. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13356 · Cited by 25
Protection induced by a Francisella tularensis subunit vaccine delivered by glucan particles
Whelan, A. O., Flick-Smith, H. C., Homan, E. J., Shen, Z. T., Carpenter, Z. K., Khoshkenar, P., Abraham, A., Walker, N. J., Levitz, S. M., Ostroff, G. R., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200213 · Cited by 26
Surface-modified yeast cells: A novel eukaryotic carrier for oral application
Kenngott, E. E., Kiefer, R., Schneider‐Daum, N., Hamann, A., Schneider, M., Schmitt, M., & Breinig, F. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.054 · Cited by 25
Lee, B. R., Jeong, S. K., Ahn, B. C., Lee, B.-J., Shin, S. J., Yum, J. S., & Ha, S. (2016) · Scientific Reports · doi:10.1038/srep32526 · Cited by 27
Gao, Z., Liu, X., Yu, J., Li, Z., Shi, H., Zhang, G., & Ling, J. (2025) · Carbohydrate Research · doi:10.1016/j.carres.2025.109591 · Cited by 24
Targeting the tumor immune microenvironment with “nutraceuticals”: From bench to clinical trials
Masuelli, L., Benvenuto, M., Focaccetti, C., Ciuffa, S., Fazi, S., Bei, A., Miele, M. T., Piredda, L., Manzari, V., Modesti, A., et al. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107700 · Cited by 23
Jesus, S., Bernardi, N. S., Silva, J. D., Colaço, M., Costa, J. P., Fonte, P., & Borges, O. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00208 · Cited by 24
Effects of dietary yeast extract on turkey stress response and heterophil oxidative burst activity
Huff, G. R., Dutta, V., HUFF, W. E., & Rath, N. C. (2011) · British Poultry Science · doi:10.1080/00071668.2011.600753 · Cited by 23
Antifungal Activity of Plasmacytoid Dendritic Cells and the Impact of Chronic HIV Infection
Maldonado, S., & Fitzgerald-Bocarsly, P. A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01705 · Cited by 24
Tong, J., Han, Q., Wang, S., Su, Z., Zheng, D., Shen, P., Xia, S., Huang, X., Shao, Q., & Xu, H. (2012) · Experimental Biology and Medicine · doi:10.1258/ebm.2012.012181 · Cited by 22
Nasr, S., Varshosaz, J., & Hajhashemi, V. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00099-x · Cited by 21
Álvarez, Y., Municio, C., Hugo, E., Zhu, J., Alonso, S., Hu, X., Fernández, N., & Crespo, M. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.222158 · Cited by 21
Rodríguez, M., Domingo, E., Alonso, S., Frade, J. G., Eiros, J., Crespo, M. S., & Fernández, N. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.522656 · Cited by 20
Chung, D., Thammahong, A., Shepardson, K. M., Blosser, S. J., & Cramer, R. A. (2014) · Molecular Microbiology · doi:10.1111/mmi.12626 · Cited by 21
Rodríguez, M. R., Márquez, S., Montero, O., Alonso, S., Frade, J. G., Crespo, M. S., & Fernández, N. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.12.001 · Cited by 19
Ahn, J. W., Kim, J. H., & Park, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010177 · Cited by 18
Soto, E. R., Specht, C. A., Rus, F., Lee, C. K., Abraham, A., Levitz, S. M., & Ostroff, G. R. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.03.027 · Cited by 18
Figueiredo, S., Cutrìn, J. C., Rizzitelli, S., Luca, E. D., Moreira, J. N., Geraldes, C. F. G. C., Aime, S., & Terreno, E. (2012) · Molecular Imaging and Biology · doi:10.1007/s11307-012-0603-x · Cited by 18
Upadhyaya, B., & Manjunath, R. (2009) · Yeast · doi:10.1002/yea.1676 · Cited by 18
Glucan Particles as Carriers of Nanoparticles for Macrophage-Targeted Delivery
Soto, E. R., & Ostroff, G. R. (2012) · ACS symposium series · doi:10.1021/bk-2012-1119.ch003 · Cited by 18
Wu, Y., Jin, Q., Chen, Y., Li, H., Deng, C., Sun, Z., Li, Y., Wang, B., Li, H., Wu, C., et al. (2020) · Biomaterials Science · doi:10.1039/d0bm01028f · Cited by 17
The Modular Nature of Dendritic Cell Responses to Commensal and Pathogenic Fungi
Rizzetto, L., Buschow, S. I., Beltrame, L., Figdor, C. G., Schierer, S., Schuler, G., & Cavalieri, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042430 · Cited by 17
Dowdall, N., & Hoare, T. R. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202501006 · Cited by 16
Kuznetsova, T. A., Persiyanova, E. V., Ermakova, S. P., Khotimchenko, M., & Besednova, N. N. (2018) · Natural Product Communications · doi:10.1177/1934578x1801300837 · Cited by 15
Metadata
- Authors
- Huang, H., Ostroff, G. R., Lee, C. K., Wang, J. P., Specht, C. A., & Levitz, S. M.
- Affiliations
- Department of Medicine
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Levitz, Stuart M.
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 2009-05
- Volume
- 77
- Issue
- 5
- Pages
- 1774-1781
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- PMC
- PMC2681737
- OpenAlex
- W2147497666
- Cited by
- 146
- References
- 54
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 5 · 2023: 2 · 2022: 1 · 2021: 9 · 2020: 6 · 2019: 13 · 2018: 10 · 2017: 10 · 2016: 12 · 2015: 17 · 2014: 12 · 2013: 6 · 2012: 10
- FWCI
- 5.32
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Infection and Immunity (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R01AI025780, R01AI066087)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- β-glucan, scleroglucan, dendritic cells, cytokine production, TLR agonists, Dectin-1, TNF-α, IL-12p70, costimulation, lipopolysaccharide, CpG, Pam3CSK4, monocyte-derived dendritic cells, vaccine adjuvants
- MeSH terms
- Dectin-1, Animals, Cells, Cultured, Dendritic Cells, Humans, Membrane Proteins, Nerve Tissue Proteins, Saccharomyces cerevisiae, Down-Regulation, Up-Regulation, Cytokines, Mice, Knockout, Lectins, C-Type, beta-Glucans, Toll-Like Receptors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review